Cargando…

Patients with non-relapsing ANCA-associated vasculitis have increased numbers of circulating IL-10 producing Th17 cells

Detalles Bibliográficos
Autores principales:	Wilde, B, Thewissen, M, van Paassen, P, Hilhorst, M, Damoiseaux, J, Witzke, O, Cohen Tervaert, J W
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007809/ http://dx.doi.org/10.1186/1479-5876-8-S1-P62

Ejemplares similares

T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
por: Wilde, Benjamin, et al.
Publicado: (2010)

Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy
por: Wilde, Benjamin, et al.
Publicado: (2012)

The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells
por: Werner, Kai, et al.
Publicado: (2019)

Endothelial progenitor cells are differentially impaired in ANCA-associated vasculitis compared to healthy controls
por: Wilde, B., et al.
Publicado: (2016)

Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
por: Kemna, Michael J., et al.
Publicado: (2017)

Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
por: Slot, Marjan C, et al.
Publicado: (2006)

Abnormal Expression Pattern of the IL-2 Receptor β-Chain on CD4(+) T Cells in ANCA-Associated Vasculitis
por: Wilde, Benjamin, et al.
Publicado: (2014)

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study
por: Ysermans, Renée, et al.
Publicado: (2022)

Automatic Reading of ANCA-Slides: Evaluation of the AKLIDES System
por: Damoiseaux, Jan, et al.
Publicado: (2012)

CD4(+)CD28(null) T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis
por: Slot, Marjan C., et al.
Publicado: (2017)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Early and late ANCA vasculitis relapses after kidney transplantation may have different presentations
por: Masset, Christophe, et al.
Publicado: (2022)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
por: Salama, Alan D.
Publicado: (2019)

Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis
por: Yoo, Juyoung, et al.
Publicado: (2018)

Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis
por: Manrique, Joaquin, et al.
Publicado: (2020)

Predictors of relapses in ANCA-associated small vessel vasculitis with kidney involvement
por: Iuliana, Andreiana, et al.
Publicado: (2014)

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis
por: Monach, Paul A., et al.
Publicado: (2012)

Do Relapses Follow ANCA Rises? A Systematic Review and Meta-Analysis on the Value of Serial ANCA Level Evaluation
por: Al-Soudi, Aram, et al.
Publicado: (2022)

Exploring Frequencies of Circulating Specific Th17 Cells against Myeloperoxidase and Proteinase 3 in ANCA Associated Vasculitis
por: Martinez Valenzuela, Laura, et al.
Publicado: (2019)

ANCA-Associated Vasculitis Clinical Presentation and Clinical Predictors of Relapse in Saudi Arabia
por: Alahmari, Hana, et al.
Publicado: (2021)

The association between ambient UVB dose and ANCA-associated vasculitis relapse and onset
por: Scott, Jennifer, et al.
Publicado: (2022)

Phenotypic Characterization of Circulating CD4(+) T Cells in ANCA-Associated Vasculitis
por: Lilliebladh, Sandra, et al.
Publicado: (2018)

DNA extraction from long-term stored urine
por: Hilhorst, Marc, et al.
Publicado: (2013)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise
por: Wojcik, Iwona, et al.
Publicado: (2023)

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
por: Zycinska, K, et al.
Publicado: (2009)

Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
por: McClure, Mark E, et al.
Publicado: (2020)

Contrasting genetic association of IL2RA with SLE and ANCA – associated vasculitis
por: Carr, Edward J, et al.
Publicado: (2009)

Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2009)

Safety and T Cell Modulating Effects of High Dose Vitamin D(3) Supplementation in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2010)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_saj7grr8k2a7a00kmsuog99u7p